e-health, Pharma 12/6/07 e-health, Pharma 12/6/07 What if Google finds out you have cancer before you do? Read More Medical travel/medical..., Pharma 11/20/07 Medical travel/medical..., Pharma 11/20/07 Medical tourism and the impact on pharmaceuticals Read More e-health, Entrepreneurs, Pharma, Physicians, Podcast 11/19/07 e-health, Entrepreneurs, Pharma, Physicians, Podcast 11/19/07 Interview with Dr. Marlene Beggelman, Founder of Enhanced Medical Decisions, Inc. (transcript) Read More e-health, Entrepreneurs, Patients, Pharma, Physicians, Podcast 11/16/07 e-health, Entrepreneurs, Patients, Pharma, Physicians, Podcast 11/16/07 Interview with Dr. Marlene Beggelman, Founder of Enhanced Medical Decisions, Inc. Read More Pharma, Policy and politics, Uncategorized 11/14/07 Pharma, Policy and politics, Uncategorized 11/14/07 FDA responds on Avastin Read More Pharma, Policy and politics 11/14/07 Pharma, Policy and politics 11/14/07 Some more answers from Genentech Read More Pharma, Physicians, Policy and politics 11/13/07 Pharma, Physicians, Policy and politics 11/13/07 Genentech tries to allay the concerns of ophthalmologists Read More Pharma, Policy and politics 11/1/07 Pharma, Policy and politics 11/1/07 Interview with Genentech re: Avastin distribution changes Read More Pharma, Policy and politics 10/31/07 Pharma, Policy and politics 10/31/07 Avastin update: Still seeking answers Read More Economics, Pharma, Policy and politics 10/30/07 Economics, Pharma, Policy and politics 10/30/07 Latest developments in the Avastin/Lucentis saga raise new questions Read More Pharma 10/25/07 Pharma 10/25/07 TV time Read More Economics, Pharma 10/18/07 Economics, Pharma 10/18/07 With Aventis (dba Lucentis) a little dab will do ya', and that's a problem for Genentech Read More Pharma, Policy and politics 10/4/07 Pharma, Policy and politics 10/4/07 PG-13 for drugs Read More Pharma 9/19/07 Pharma 9/19/07 AstraZeneca to outsource manufacturing: not such a no-brainer Read More Pharma 9/14/07 Pharma 9/14/07 Regulate or self-regulate? Read More Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 Look for a nice bump in investigator initiated trials Read More Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 No biogeneric legislation this year Read More Economics, Pharma, Policy and politics 8/30/07 Economics, Pharma, Policy and politics 8/30/07 Abusing the orphan drug law to rip off customers Read More Pharma, Policy and politics 8/29/07 Pharma, Policy and politics 8/29/07 Regulation of Follow-on Biologics: Still missing the point Read More Culture, Pharma 8/21/07 Culture, Pharma 8/21/07 There is no pain you are receding Read More Newer Posts Older Posts
e-health, Pharma 12/6/07 e-health, Pharma 12/6/07 What if Google finds out you have cancer before you do? Read More
Medical travel/medical..., Pharma 11/20/07 Medical travel/medical..., Pharma 11/20/07 Medical tourism and the impact on pharmaceuticals Read More
e-health, Entrepreneurs, Pharma, Physicians, Podcast 11/19/07 e-health, Entrepreneurs, Pharma, Physicians, Podcast 11/19/07 Interview with Dr. Marlene Beggelman, Founder of Enhanced Medical Decisions, Inc. (transcript) Read More
e-health, Entrepreneurs, Patients, Pharma, Physicians, Podcast 11/16/07 e-health, Entrepreneurs, Patients, Pharma, Physicians, Podcast 11/16/07 Interview with Dr. Marlene Beggelman, Founder of Enhanced Medical Decisions, Inc. Read More
Pharma, Policy and politics, Uncategorized 11/14/07 Pharma, Policy and politics, Uncategorized 11/14/07 FDA responds on Avastin Read More
Pharma, Policy and politics 11/14/07 Pharma, Policy and politics 11/14/07 Some more answers from Genentech Read More
Pharma, Physicians, Policy and politics 11/13/07 Pharma, Physicians, Policy and politics 11/13/07 Genentech tries to allay the concerns of ophthalmologists Read More
Pharma, Policy and politics 11/1/07 Pharma, Policy and politics 11/1/07 Interview with Genentech re: Avastin distribution changes Read More
Pharma, Policy and politics 10/31/07 Pharma, Policy and politics 10/31/07 Avastin update: Still seeking answers Read More
Economics, Pharma, Policy and politics 10/30/07 Economics, Pharma, Policy and politics 10/30/07 Latest developments in the Avastin/Lucentis saga raise new questions Read More
Economics, Pharma 10/18/07 Economics, Pharma 10/18/07 With Aventis (dba Lucentis) a little dab will do ya', and that's a problem for Genentech Read More
Pharma 9/19/07 Pharma 9/19/07 AstraZeneca to outsource manufacturing: not such a no-brainer Read More
Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 Look for a nice bump in investigator initiated trials Read More
Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 No biogeneric legislation this year Read More
Economics, Pharma, Policy and politics 8/30/07 Economics, Pharma, Policy and politics 8/30/07 Abusing the orphan drug law to rip off customers Read More
Pharma, Policy and politics 8/29/07 Pharma, Policy and politics 8/29/07 Regulation of Follow-on Biologics: Still missing the point Read More
